Clinical Trials Browser

Phase 2 × Breast Neoplasms × ruxolitinib × Clear all

NCT02876302 2026-02-04

Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

Phase 2 Active not recruiting

23 enrolled 18 charts

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02955940 2025-12-17

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

Phase 2 Active not recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02120417 2018-02-13

A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer

Phase 2 Terminated

149 enrolled 14 charts

Breast Neoplasms

NCT01562873 2017-02-23

Ruxolitinib in Patients With Breast Cancer

Phase 2 Terminated

21 enrolled 7 charts

Breast Neoplasms